Ampullary Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Ampullary Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels [Phase 2]
Phase 2 Yale-sponsored trial evaluating adding sequential cytoreductive intervention to standard-of-care therapy for metastatic foregut aden…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Robotic Versus Open Pancreaticoduodenectomy for Pancreatic and Periampullary Tumors [NA]
A completed clinical trial comparing robotic versus open pancreaticoduodenectomy for pancreatic and periampullary tumors.
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: PRODIGE 98 : Randomized, Multicenter Phase 3 Trial of Adjuvant Chemotherapy With Modified FOLFIRINOX Versus Capecitabine or Gemcitabine in Patients With Resected Ampullary Adenocarcinoma [Phase 3]
A Phase 3 randomized trial compares adjuvant modified FOLFIRINOX with Capecitabine or Gemcitabine in patients who have undergone resection f…
-
CLINICAL_TRIALS research · 2024-05-30Clinical Trial Update: Quantitative Nodal Burden as a Determinant Identifying Ampullary Adenocarcinoma Patients Benefiting From Adjuvant Chemotherapy
A clinical trial assessing whether quantitative nodal burden can identify ampullary adenocarcinoma patients who will benefit from adjuvant c…
-
CLINICAL_TRIALS trial_result · 2010-08-12Clinical Trial Update: Study of S-1 Oxaliplatin (SOX) for Biliary Tract Cancer (BTC) (Ampullary Adenocarcinoma) [Phase 2]
Phase 2 trial evaluating the SOX regimen (S-1 plus oxaliplatin) for biliary tract cancer, including ampullary adenocarcinoma; sponsor listed…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.